Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ixmyelocel-T in Osteonecrosis of the Femoral Head
NCT00505219Phase 3Completed
- Sponsor
- Vericel
- Start
- Sep 2007
- Primary completion
- Sep 2010
- Modality
- Mesenchymal Stem Cells, Hematopoietic Stem Cells
- Countries
- 1
01
Overview
A Phase 3 trial of ixmyelocel-T in osteonecrosis of the femoral head (ONFH), sponsored by Vericel. Started Sep 2007; status: completed.
02
Drugs
ixmyelocel-T
03
Conditions
osteonecrosis of the femoral head (ONFH)
Beyond the preview
Go deeper on NCT00505219.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00505219.